Electrophysiology Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Electrophysiology Devices Market

According to a new market report published by Transparency Market Research "Electrophysiology Devices Market (ECG, EEG, Holter Monitoring Systems, Diagnostic Electrophysiology Catheters, Pacemaker, Imaging and 3D Mapping Systems) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global electrophysiology devices market was valued at USD 2,500.0 million in 2012 and is estimated to reach a market worth USD 5,496.6 million in 2019 at a CAGR of 12.1% from 2013 to 2019.

Browse the full report with Complete TOC at http://www.transparencymarketresearch.com/electrophysiology-ep-devices-market.html

Electrophysiology is the study of electrical properties of biological cells. Electrophysiology devices are used for diagnosing and treating abnormal electrical activities in the heart, brain and eyes. The market for electrophysiology devices is expected to grow impressively with the rise in prevalence of cardiac diseases, increasing healthcare expenditure and technological advancements. With the rising adoption of ablation techniques especially for the treatment of atrial fibrillation, the electrophysiology market is expected to grow rapidly. On the other hand, strict regulatory approvals, high costs associated with devices coupled with availability of alternate medications are some of the challenges faced by the electrophysiology devices market.

Get Free Sample Report at http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=391

The market for electrophysiology devices primarily comprises electrophysiology monitoring devices and treatment devices. Monitoring devices used in electrophysiology include electrocardiograph, electroencephalograph, electromyography, electroretinograph, diagnostic catheters and others. These devices enable physicians to understand the nature and origin of abnormal electrical impulses generating in the single ion channel cells to organs like the heart, brain and eyes. The outcomes help physicians in proper decision-making regarding treatment options, whether a patient needs medication or should opt for cardiac arrhythmic device implantation or catheter assisted ablation. Catheter ablation is a relatively new technique compared to implantation of cardiac arrhythmias devices. Due to its minimal invasive nature and efficacy, catheter ablation is the most commonly used treatment option for atrial fibrillation and other cardiac arrhythmias.

Browse all Medical Devices Market Research Reports @ http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html

North America constitutes the largest market for electrophysiology devices. Factors such as presence of large number of well-equipped healthcare facilities, rising prevalence of diseases (cardiac arrhythmias, ophthalmic disorders and epilepsy) that require electrophysiology monitoring, and established healthcare policies providing access to better healthcare facilities are driving the market in the region. The fact that majority of the key players in the electrophysiology market including Medtronic Inc., St. Jude Medical and Boston Scientific are based in the U.S. and consider this as their primary revenue generating market, also acts as a driver. In addition, economic liberalization in emerging nations such as India, China, Brazil, Mexico, South Africa and Russia is attracting manufacturers to shift their focus to these regions. The above mentioned shift in focus will help Asia-Pacific and Rest of the World (RoW) to increase their market share during the forecast period. Asia-Pacific has been anticipated to emerge as the fastest growing geography during the forecast period from 2013 to 2019.

Some of the key market players of the global electrophysiology devices market include St. Jude Medical, Boston Scientific, Medtronic, Inc., Philips Healthcare and others. To gain a proficient market share, manufacturers are coming up with innovative products. The global electrophysiology devices market includes companies such as Abbott Laboratories, Boston Scientific, Medtronic, Inc., GE Healthcare, Philips Healthcare, St. Jude Medical among others.

Downlaod PDF at Electrophysiology Devices Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

Implantable Drug Delivery Devices Market - Global Industry Analysis, Size, Share, Trends And Forecast 2012 – 2018

Implantable Drug Delievery Devices Market

According to a new market report published by Transparency Market Research "Implantable Drug Delivery Devices (Contraceptives, Drug Infusion Pumps, Intraocular Implants, Drug Eluting, Bio-absorbable Stents, Biodegradable) Market- Global Industry Analysis, Size, Share, Trends and Forecast, 2012 - 2018," in 2011, the global market for implantable drug delivery devices was calculated at USD 11.6 billion and is expected to grow at a CAGR of 8.8% from 2012 to 2018, to reach an estimated value of USD 21.1 billion in 2018.

Browse the Implantable Drug Delivery Market Research Report at http://www.transparencymarketresearch.com/implantable-drug-delivery-devices.html

A growing prevalence of target disease segments such as prostate cancer, diabetic retinopathy, chronic pain causing diseases, cardiovascular diseases, colorectal cancer, a rising global prevalence of unwanted pregnancies and a rapidly aging global population are some of the most impact rendering drivers for the global implantable drug delivery devices market. Some of the other drivers for the market include government and NGO initiatives undertaken to promote contraceptive drug delivery implants, rising number of interventional cardiologists and the rising demand for minimally invasive surgeries. Introduction of biodegradable implantable drug delivery technologies and new products such as MicroChips catering to disease segments such as osteoporosis will serve the market as future growth opportunities.

Get Free Sample Report at http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=887

The market for implantable drug delivery devices in cardiovascular applications held majority of the market share in 2011 and owing to the introduction of bio-absorbable stents expected in 2014, its market share is likely to witness further increase by 2018. The biodegradable drug delivery implant technology will grow at a faster CAGR in comparison to the non-biodegradable drug delivery implant technology due to the fact that they do not involve re-surgeries for device removal and eliminates side effects induced by the prolonged presence of the device in the body.

Browse all Medical Devices Market Research Reports @ http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html

The North American implantable drug delivery devices market held majority of the market share in 2011. However, its market share is expected to drop by 2018 owing to the accelerated market growth in the Asian regions induced by the economic development of emerging nations with high unmet medical needs such as India and China.

Merck held a majority of the market share in the global contraceptive drug delivery implants market due to the high adoption rate of its implants namely NuvaRing, Implanon and Implanon Nxt. Merck is closely followed by Bayer HealthCare with its widely used hormonal IUD Mirena and the launch of a new hormonal IUD Skyla in the U.S. and Jaydess in Europe in 2013.

Download PDF at Implantable Drug Delivery Devices Market - Global Industry Analysis, Size, Share, Trends And Forecast 2012 – 2018

Medical Imaging Equipment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

medical Imaging equipment market

According to a new market report published by Transparency Market Research "Medical Imaging Equipment Market (X-ray, Ultrasound, Computed Tomography (CT), Magnetic Resonance Imaging (MRI) and Nuclear Imaging Equipment) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," in 2012, the global medical imaging equipment market was valued at USD 24.39 billion and is expected to grow at a CAGR of 5.4% during the forecast period of 2013 to 2019 to reach a market value of USD 35.35 billion by 2019.

Browse the full report with complete TOC at http://www.transparencymarketresearch.com/medical-imaging-equipment-market.html

Medical imaging equipment helps in diagnosing various complex diseases such as chromosomal abnormalities, atherosclerosis and Parkinson's disease. This equipment utilizes energy waves to produce 2-D and 3-D images of human organs. With rise in incidences of various diseases such as cardiovascular diseases (CVD), brain disorders, oral conditions such as gingivitis, and lung disorders, the market is expected to grow at a CAGR of 5.4% during the forecast period of 2013 to 2019.

According to an estimate of the World Health Organization (WHO), around 8.7 million people suffered from tuberculosis (TB) in 2011 worldwide and around 23.3 million people will die due to CVDs. Growth of this market will also be supported by the increasing geriatric population worldwide because elderly people are highly susceptible to various diseases such as osteoporosis, stroke and CVDs. Equipment such as nuclear imaging devices and computed tomography (CT) scanners help in diagnosing these diseases precisely within a short span of time. Moreover, introduction of various technologically advanced products such as handheld X-ray machines and upright MRI scanners will also augment growth of this market. This is attributed mainly to increase in their utilization in various medical institutes, such as hospitals and diagnostic labs, since they reduce installation cost and also provide convenience of use.

Get Free Sample Report at http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=105

Likewise, support from various private and government bodies will also trigger the growth of this market. For instance, the U.S. government introduced the Medicare Benefit Schedule (MBS) in 2011 which provides rebates for different categories of items including medical devices. However, imposition of excise tax on the sale of medical devices by the manufacturers and low adoption rate in patients for conventional MRI and CT scanners will hamper the growth of this market. According to the Patient Protection and Affordable Care Act (PPACA) of the U.S., medical device manufacturers are expected to pay an additional medical device excise tax (MDET) of 2.3% on the sale of every device.

Browse all Medical Devices Market Research Reports @ http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html

The CT scanners and nuclear imaging equipment market segments are expected to show the highest growth among all market segments due to their capability to diagnose large number of diseases effectively in less time. The market for CT scanners was valued at USD 4.35 billion and that for nuclear imaging equipment was value at USD 1.47 billion, in 2012. Both these market segments are expected to show growth at a CAGR of over 5% each.

Geographically, the North American region constituted the largest share by revenue for medical imaging equipment in the year 2012; however, Asia-Pacific is predicted to foresee the highest growth rate of over 7% from 2013 to 2019. This is attributed to rise in geriatric population, and improving healthcare infrastructure in the Asia-Pacific region. In addition, the favorable demand-supply gap for diagnostic services in this region will also propel the growth of this market.

The global medical imaging equipment market is dominated by players such as GE Healthcare, Toshiba America Medical System, Philips Healthcare, Shimadzu Corporation., Siemens Healthcare and Hitachi Medical Corporation. The market is highly oligopolistic in nature with the top three players accounting for about 50% of the global market revenue.

Download PDF at Medical Imaging Equipment Market in 2013 – 2019: Transparency Market Research

Artificial Vital Organs and Medical Bionics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 – 2018

Artificial Vital Organs and Medical Bionic market

According to a new market research report published by Transparency Market Research "Artificial Vital Organs and Medical Bionics Market(Artificial Heart, Kidney, Liver, Pancreas & Lungs, Ear Bionics, Vision Bionics, Exoskeletons, Bionic Limbs, Brain Bionics and Cardiac Bionics)- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018," in 2011, the artificial vital organs and medical bionics market was valued at USD 17.5 billion and it is expected to grow at a CAGR of 9.2% from 2012 to 2018, to reach an estimated value of USD 32.3 billion in 2018.

Browse the full report at http://www.transparencymarketresearch.com/artificial-vital-organs-medical-bionics.html

An artificial organ is a man-made device, which is integrated or implanted into the patient, to replace an original diseased organ and restore its specific function. Medical bionics is the study of application of mechanics and electronics to replace a limb or other part of a functional organ that is mechanically powered. With rapid development in healthcare technology, organ transplantation has evolved as a common surgical practice. With years of extensive research and development in the field of medical devices and related technological innovations, artificial vital organs and medical bionics are successfully established as viable alternatives for the replacement of donor organs as the latter are not able to keep pace with an increase in demand for efficient rehabilitation of the physically challenged.

The global artificial vital organs market is segmented into artificial heart, kidney, lungs, liver and pancreas markets. The market for artificial vital organs is led by the artificial kidney segment, in terms of revenue. Increase in prevalence of renal disorders and acute renal failure due to the sedentary lifestyle is a major driver for this market. Increase in the prevalence of cardiovascular diseases leading to acute cardiac failure has led to a growing need for heart replacement. Also, the number of patients awaiting transplant are far more than the availability of donor organs and this has led to an increase in the demand for total artificial heart (TAH). The market for total artificial heart is expected to grow at a CAGR of more than 9% from 2012 to 2018.

Get Free Sample Report at http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1271

The medical bionics market is categorized into ear bionics (cochlear implants), vision bionics, exoskeletons, bionic limbs, brain bionics and cardiac bionics. High prevalence of occupation and age-related disabilities demands novel methods of patient rehabilitation to offer a better life for such patients. The market for exoskeletons is expected to emerge as the fastest growing segment, at a CAGR of over 15% from 2012 to 2018.

Geographically, North America leads the market for artificial vital organs and medical bionics. Aging of the baby boomer population and the corresponding rise in prevalence of acute cases of cardiovascular diseases, renal diseases and respiratory disorders, and the increase in prevalence of age-related disorders and occupation-related disabilities are the major drivers for the growth in demand for artificial organs in North America. However, improvement in healthcare expenditure and healthcare infrastructure and rising scope of medical tourism will increase the market share of Asia-Pacific in the future.

Browse all Medical Devices Market Research Reports@ http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html

The key players in the artificial vital organs and medical bionics market include Abbott Diabetes Care, Abiomed, Inc., Asahi Kasei Medical Co., Ltd., Baxter International, Inc., Gambro AB, Medtronic, Inc., Nikkiso Co., Ltd., SynCardia Systems, Inc., Ossur Hf, WorldHeart Corporation, Ekso Bionics, Touch Bionics, Ottobock Healthcare Gmbh, Second Sight Medical Products, Inc. and others.

Download PDF at Artificial Vital Organs and Medical Bionics Market in 2012 – 2018: Transparency Market Research

Home Healthcare Market - Global Industry Size, Market Share, Trends, Analysis And Forecast 2012 – 2018

Home Healthcare Market

According to a new market report published by Transparency Market Research , "Home Healthcare Market - Global Industry Size, Market Share, Trends, Analysis and Forecast, 2012 - 2018", the global home healthcare market is estimated to be worth USD 195.6 billion in 2012 and is expected to reach the value of USD 305.9 billion by 2018, growing at a CAGR of 7.7% from 2012 to 2018. The Americas region is expected to lead the global home healthcare market in terms of revenue till 2018. The total home healthcare market in the Americas is expected to reach the value of USD 150.8 billion by 2018 followed by Europe with total revenue of USD 80.5 billion.

Browse the full report at http://www.transparencymarketresearch.com/home-healthcare-market.html

The rising need to continuously monitor and care for health has increased the global expenditure on healthcare services and products. The trend is also gradually pushing people towards home healthcare products and services, due to their cost efficiency and reliability. This, in turn, is driving the growth of the global home healthcare products and services market. The technological and application developments that have taken place in the home healthcare segment have made them more reliable and globally acceptable. It has also made it feasible for hospitals and patients to get early discharge, and minimize the cost and infrastructure pressures. The growth in certain diseases or medical conditions such as high blood pressure, diabetes, asthma, and other cardiovascular and respiratory diseases, which require continuous monitoring and care, are further driving the home healthcare market growth.

Get Free Sample Report at http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=300

Though the global share of the home healthcare equipment market is considerably less, it is growing at a faster CAGR of 9.9% from 2012 to 2018 due to rising technological innovations, especially in the field of home therapeutic equipment. The home healthcare services market, despite its large share, is expected to grow at a CAGR of 7.4% from 2012 to 2018. The main deterrent, restricting the entry of organized players in this segment is dominance of a large number of small regional players, who are offering their services at low prices, and enjoy high customer loyalty. This has in turn, shifted the attention of big players towards the home healthcare equipment market.

The global home healthcare equipment market can be categorized as: therapeutic equipment market, self-diagnostic and monitoring equipment market, mobility assists equipment market, and others. Currently, the key market players dominating the home healthcare equipment market are: J&J (Johnson and Johnson), Braun, GE Healthcare, Baxter International, Philips Healthcare, Omron Corporation, Invacare, and Medtronic.

The global market for home healthcare services is classified into respiratory therapy, telemetry, rehabilitation services, infusion therapy, and other unskilled home healthcare services. The unskilled healthcare services are provided by individuals such as family members, unlicensed or traditional caretakers, relatives, and friends. The market for home healthcare services is highly organized in regions such as the Americas and Europe, where it is very efficient. A large share, 79.9%, of the global home healthcare services market is dominated by rehabilitation and unskilled care services. However, the segment is believed to be extremely fragmented, and dominated by small and unorganized players.

Browse all Medical Devices Market Research Reports Research Reports @ http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html

This research is specially designed to estimate and analyze the demand and performance of home healthcare equipment and services in a global scenario. The research provides in-depth analysis of home healthcare equipment manufacturers, product sales, trend analysis by segments and demand by geography. The report covers all the major application segments of the global home healthcare market and provides in-depth analysis, historical data and statistically refined forecast for the segments covered.

Download PDF at Home Healthcare Market - Global Industry Size, Market Share, Trends, Analysis And Forecast 2012 – 2018

Minimally Invasive Vertebral Compression Fracture Repair Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

Minimally Invasive Vertebral Compression Fracture Repair Market

According to a new market report published by Transparency Market Research "Minimally Invasive Vertebral Compression Fracture Repair Market (Vertebroplasty and Kyphoplasty Devices) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019", the global minimally invasive vertebral compression fracture repair market was valued at USD 1.58 billion in 2012 and is expected to grow at a CAGR of 8.7%from 2013 to 2019, to reach an estimated value of USD 2.82 billion in 2019.

Browse Minimally Invasive Vertebral Compression Fracture Repair Market Report with Full TOC at http://www.transparencymarketresearch.com/vertebral-compression-fracture-repair.html

Minimally invasive vertebral compression fracture (VCF) repair is one of the fastest growing segments in the overall spinal surgeries market. Factors such as growth in incidence of vertebral compression fractures, high prevalence of osteoporosis, aging of population worldwide and inability of medicinal therapy to cure vertebral compression fracture to the optimum level will have an impact on the growth of the minimally invasive vertebral compression fracture repair industry.

The global minimally invasive vertebral compression fracture repair market is segmented on the basis of types of procedural technology and geography. Based on technology, the minimally invasive VCF repair market is classified into vertebroplasty and kyphoplasty devices. It is expected that the global market for kyphoplasty will reach USD 1.47 billion in 2019 growing at a CAGR of 11.7% from 2013 to 2019.

Get Free Sample Report at http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1788

The United States currently leads the minimally invasive VCF repair market, owing to the early bird advantage rendered by the first launch of innovative products in the country. Growth drivers in the North American minimally invasive VCF repair market include existence of well-defined reimbursement policies, supportive economic base particularly in terms of medical reimbursement, high awareness about VCF conditions and the treatments available. However, countries such as China, Japan, Korea, Australia and India are observed to be potentially emerging markets with higher aging population, development of healthcare infrastructure, high prevalence of osteoporosis and rise in general awareness about healthcare. Countries such as Brazil, Mexico and Argentina are some of the lucrative markets in the Rest of the World.

Browse all Medical Devices Market Research Reports Research Reports @ http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html

The global minimally invasive VCF repair market is highly consolidated in nature with companies like Medtronic, Inc. dominating the market with more than 80% of the market share. Some of the other key market players operating in this market include Alphatec Spine, Inc., CareFusion Corporation, Cook Medical, Inc., DFine, Inc., Zimmer Holdings, Globus Medical, Inc. and DePuySynthes, Inc.

Download PDF at Minimally Invasive Vertebral Compression Fracture Repair Market -in 2013 – 2019: Transparency Market Research

Orthopedic Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

According to a new market report published by Transparency Market Research "Orthopedic Devices Market (Hip, Knee, Spine, Shoulder, Elbow, Foot and Ankle, Craniomaxillofacial and Other Extremities) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global orthopedic devices market was valued at USD 29.2 billion in 2012 and is expected to grow at a CAGR of 4.9% from 2013 to 2019, to reach an estimated value of USD 41.2 billion in 2019.

Browse Orthopedic Devices Market Report with Full TOC at http://www.transparencymarketresearch.com/orthopedic-devices-market.html

Orthopedic devices are used to provide or restore stability by placing them within the body's skeleton. These help in correcting the problems associated with the bone and joints such as injuries or deformities. Insertion of these orthopedic devices such as joint implants, internal and external fixators involves surgical procedures which can be minimally invasive. Growing elderly population combined with the rise in risk for osteoporosis, osteoarthritis, injuries and obesity, contribute to the growth of this market particularly in emerging economies of the Middle East, and the Asian countries such as China and India.Furthermore, technological advancementssuch asbio-absorbableimplants coupled with increase in the success rate of these implants and fixators in the emerging market, will serve as an opportunity for investors to invest in.

The global market for orthopedic deviceshas been studied from the perspective of widely used various orthopedic devices and number of procedures for particular anatomical location.The report provides a detailed analysis of orthopedic devices for hip, knee, shoulder, elbow, foot and ankle, and other extremities. These are further segmented into joint implants, internal fixation devices and external fixation devices. The others extremities segment comprises the market for wrists, digits and hand. The market has also been estimated for spinal orthopedic devices which includes cervical and thoracolumbar spinal implants and the internal fixation devices. Moreover, orthopedic devices for craniomaxillofacial comprises only of internal fixation devices.

Get Free Sample Report at http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1781

In 2012, knee orthopedic devices accounted for the largest share by revenue of the total orthopedic devices market. However, the product recalls caused dueto factors such as implant loosening, corrosion, wear, and manufacturing errors are expected to have a major impact on the overall marketrevenue. Thus, the U.S. and European markets are anticipated to see a decline in growth during the forecast period.The market for hip orthopedic productsaccounted for the second largest share in 2012. It is estimated that the global market for hip deviceswill grow at a CAGR of over 5.9% from 2013 to 2019, owing to its high incidence rate of hip fractures and demand for hip replacement procedures.

The report also provides market estimations for orthopedic consumables during the forecast period of 2013 to 2019. This market has been segmented as anchors and staples. Anchors form a major share of the total orthopedic consumables market contributing to around 80% of the market share in 2012. The overall orthopedic consumables market is expected to grow to reach a value of USD 457 million by 2019.

Browse all Medical Devices Market Research Reports @ http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html

Geographically, North America dominatedthe global market for orthopedic devices in terms of revenue generation and is expected to maintain its position throughout the forecast period. The adoption of bio absorbable implants, growing elderly population and rise in incidences of osteoporosis, osteoarthritis, and obesity in the U.S., consequently leading to various types of fractures, is expected to contribute to the leadership of the North American market. Europe was the second largest regional market for orthopedic devicesin 2012, owing to the increased demand for drug eluting stents and infusion pumps. Asia-Pacific is expected to be the fastest growing region in the global orthopedic devices marketfrom 2013 to 2019.

The global hip and knee orthopedic devices market is dominated by major players including Depuy Synthes, Zimmer and Stryker, while the overall spinal devices market is dominated by Medtronic, Depuy, Styrker and NuVasive.

Download PDF at Orthopedic Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019